1FIRE A,XU S,MONTGOMETRY MK,et aL.Potent and specific interference by double-stranded RNA in caenorhabditis elegans[J].Nature,1998,391 (6669):806.
2HAMMOND M.Dicing and slicing:the core machinery of the RNA interference pathway[J].FEBS Lett,2005,579 (26):582225829.
3RIVAS FV,TOLIA NH,SONG JJ,et al.Purified Argonaute2 and an siRNA form recombinant human RISC[J].Nat Struct MolBiol,2005,12(4):3402349.
4JACKSON AL,BURCHARD J,LEAKE D,et al.Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing[J].RNA,2006,12:1197-1205.
5KAWASAKI H,TAIRA K.Induction of DNA methylation and gene silencing by short interfering RNAs in human cells[J].Nature,2004,431 (7005):2112217.
6ZENG Y,YI R,CULLEN BR.Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha[J].EM-BOJ,2005,24(1):138-148.
7GRISHOK A,PASQULNELLI AE,CONTE JM,et al.Genes and mechanisms related to RNA interference regulate expression of small temporal RNAs that control C.elegants developmental timing[J].Cell,2001,106 (1):23224.
9PHAM JW,PELLINO JL,LEE YS,et al.A Dicer222dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila[J].Cell,2004,117(1):83294.
10WINSTON WM,MOLODWITCH C,HUNTER CP.Systemic RNAi in Celegans requires the putative transmembrane protein SID21[J].Science,2002,295 (5564):2456-2459.
二级参考文献15
1Lee NS,Dohjima T,Bauer G,et al.Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.NatBiotechnol,2002,20(5):500-505.
2Li L, Yuan L, Luo J, et al. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Survivin and SIRTI[J]. Clin Exp Med, 2013, 13(2) :109-117.
3Sandy H, Ralf W, Aehim A, et al. RNA interference targeting Survivin exerts antitumoral effeels in vitro and in established glio- ma xenografts in vivo [J]. Neuro Oncology, 2011, 13 (10) : 1074-1089.
4Tanizaki J, Okamoto I, Fumita S, et al. Roles of BIM induction and Survivin downregula/ion in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification [ J ]. Oncogene, 2011, 30(39) :4097-4106.
5Wang Y, Li Z, Han Y, et al. Nanoparticle-based delivery sys- tem for application of siRNA in vivo [ J ]. Curr Drug Metab, 2010, 11(2) :182-196.
6Singha K, Namgung R, Kim WJ. Polymers in small-interfering RNA delivery[J]. Nucleic Acid Ther, 2011, 21 (3) :133-147.
7Kong F, Liu G, Sun B, et al. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA de- livery and target gene silencing[J]. Int J Pharm, 2012, 422 (1/2) : 445-453.
8Watts JK, Deleavey GF, Damha MJ. Chemically modified siRNA: tools and applications [ J ]. Drug Discov Today, 2008, 13 ( 19/ 20) : 842-855.
9Shim MS, Kwon YJ. Efficient and targeted delivery of siRNA in vivo[ J ] . FEBS J, 2010, 277(23) :4814-4827.
10Whitehead KA, Langer R, Anderson DG. Knocking down barri- ers: advanced in siRNA delivery [ J ]. Nat Rev Drug Discov, 2009, 8(2) :129-138.
